For the Rotigotine patch - used to treat symptoms of Parkinson's disease - Shilpa Medicare has projected a global market over EUR 200 million, and has partnered with a 'strong' European player for the ...

Through this collaboration, Shilpa Biologics, the biologics arm of Shilpa Medicare, will become Alveolus Bio's exclusive global development and manufacturing partner. This partnership propels Alveolus ...

Orion Corporation and Shilpa Biocare Private Limited, a fully-owned subsidiary of Shilpa Medicare Limited (“Shilpa”), have entered into an agreement to commercialise Recombinant Human Albumin in ...

What's Shilpa Medicare Ltd share price today. Get Shilpa Medicare Ltd latest news on BSE/NSE stock price live updates, Shilpa Medicare Ltd financial results and overview, Shilpa Medicare Ltd stock ...

Get all latest & breaking news on Shilpa Medicare. Watch videos, top stories and articles on Shilpa Medicare at moneycontrol.com.

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel ...

RAICHUR, India, Aug. 14, 2025 /PRNewswire/ -- In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the ...

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections Raichur & Hyderabad, India – ...

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 ...